JNPMEDI announced on the 18th that it has signed a Memorandum of Understanding (MOU) for industry-academic cooperation, education, and research activation with Chung-Ang University's College of Pharmacy, and its Graduate Schools of Pharmaceutical Industry and Regulatory Science.
Through this agreement, both parties have agreed to jointly promote: ▲ Development and operation of education programs for cultivating pharmaceutical and biotech professionals; ▲ Mutual growth through technological and talent cooperation and exchanges; ▲ Creation and dissemination of new knowledge and technologies.
Kwunho Jung, CEO of JNPMEDI, stated, "We believe that fostering talent and establishing a technology cooperation network through this agreement will generate significant synergies for the growth of the pharmaceutical and biotech sectors. We will strive to make this collaboration a model for industry-academic exchange in the pharmaceutical and biotech fields."
Eunyoung Kim, head of the Graduate School of Pharmaceutical Industry at Chung-Ang University, commented, "This agreement will serve as a great opportunity for mutual development in joint research and talent cultivation. We will actively utilize Chung-Ang University's excellent human resources and infrastructure to contribute to advancing drug development in Korea and leading the fields of pharmacy and pharmaceutical industry."
JNPMEDI announced on the 18th that it has signed a Memorandum of Understanding (MOU) for industry-academic cooperation, education, and research activation with Chung-Ang University's College of Pharmacy, and its Graduate Schools of Pharmaceutical Industry and Regulatory Science.
Through this agreement, both parties have agreed to jointly promote: ▲ Development and operation of education programs for cultivating pharmaceutical and biotech professionals; ▲ Mutual growth through technological and talent cooperation and exchanges; ▲ Creation and dissemination of new knowledge and technologies.
Kwunho Jung, CEO of JNPMEDI, stated, "We believe that fostering talent and establishing a technology cooperation network through this agreement will generate significant synergies for the growth of the pharmaceutical and biotech sectors. We will strive to make this collaboration a model for industry-academic exchange in the pharmaceutical and biotech fields."
Eunyoung Kim, head of the Graduate School of Pharmaceutical Industry at Chung-Ang University, commented, "This agreement will serve as a great opportunity for mutual development in joint research and talent cultivation. We will actively utilize Chung-Ang University's excellent human resources and infrastructure to contribute to advancing drug development in Korea and leading the fields of pharmacy and pharmaceutical industry."